<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/rss/nolsol.xslt"?>

 









<rss version="2.0">
	<channel>
		<title>NICE | Nice Front Page (Welcome to NICE)</title>
		<link>http://www.nice.org.uk/</link>
		<description>NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.</description>
		<language>en-gb</language>
		<copyright>Copyright (c) 2007 National Institute for Health and Clinical Excellence</copyright>
		<image>
			<title>NICE</title>
			<url>http://www.nice.org.uk/images/rss-logo.gif</url>
			<link>http://www.nice.org.uk/</link>
		</image>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAnnualConference2012PublicHealthWebinar.jsp]]></guid>
			<title>NICE Annual Conference 2012 public health webinar</title>
			<description><![CDATA[NICE Annual Conference 2012 public health webinar]]></description>
			<pubdate>9 Feb 2012, 10:56:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAnnualConference2012PublicHealthWebinar.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAnnualConference2012PublicHealthWebinar.jsp]]></guid>
			<title>NICE Annual Conference 2012 public health webinar</title>
			<description><![CDATA[NICE Annual Conference 2012 public health webinar]]></description>
			<pubdate>9 Feb 2012, 10:55:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAnnualConference2012PublicHealthWebinar.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/OsteoporosisRiskAssessmentConsultation.jsp]]></guid>
			<title>NICE consultation opens on assessing risk of fragility fracture in adults</title>
			<description><![CDATA[The National Institute for Health and Clinical Excellence (NICE) today (9 February) opens a consultation on assessing the risk of fragility fracture in adults. The draft short clinical guideline aims to advise on methods to help clinicians assess who might be at risk of a fragility fracture, and will support them in identifying who will benefit from treatments that help prevent such fractures occurring.]]></description>
			<pubdate>9 Feb 2012, 09:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/OsteoporosisRiskAssessmentConsultation.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEConsultsOnNewDraftGuidelineOnSickleCell.jsp]]></guid>
			<title>NICE consults on new draft guideline on sickle cell</title>
			<description><![CDATA[The healthcare guidance body NICE has today (Wednesday 8 February) opened a consultation on the draft of its first guideline on the management of an acute painful sickle cell episode in hospital. Sickle cell is one of the most commonly inherited serious genetic disorders in England.]]></description>
			<pubdate>8 Feb 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEConsultsOnNewDraftGuidelineOnSickleCell.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://guidance.nice.org.uk/DT/4/Consultation/DraftGuidance/pdf/English]]></guid>
			<title>Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat:</title>
			<description><![CDATA[Diagnostics consultation]]></description>
			<pubdate>3 Feb 2012, 00:00:00</pubdate>
			<link><![CDATA[http://guidance.nice.org.uk/DT/4/Consultation/DraftGuidance/pdf/English]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/cof/ConsultationOnCOFIndicators.jsp]]></guid>
			<title>COF indicators</title>
			<description><![CDATA[Commissioning outcomes framework indicators]]></description>
			<pubdate>1 Feb 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/cof/ConsultationOnCOFIndicators.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://guidance.nice.org.uk/TA/Wave26/4/Scope/pdf/English]]></guid>
			<title>Prostate cancer (metastatic, castration resistant) - abiraterone (following cytoxic therapy):</title>
			<description><![CDATA[Appraisal consultation]]></description>
			<pubdate>2 Feb 2012, 00:00:00</pubdate>
			<link><![CDATA[http://guidance.nice.org.uk/TA/Wave26/4/Scope/pdf/English]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/cof/ConsultationOnCOFIndicators.jsp]]></guid>
			<title>Consultation on COF indicators:</title>
			<description><![CDATA[Commissioning outcomes framework consultation]]></description>
			<pubdate>1 Feb 2012, 09:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/cof/ConsultationOnCOFIndicators.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/cof/ConsultationOnCOFIndicators.jsp]]></guid>
			<title>Consultation on COF indicators:</title>
			<description><![CDATA[]]></description>
			<pubdate>1 Feb 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/cof/ConsultationOnCOFIndicators.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/DraftNICEGuidanceOnTestsToGuideBreastCancerTreatmentDecisions.jsp]]></guid>
			<title>Draft NICE guidance says more evidence needed on new tests to guide breast cancer treatment decisions</title>
			<description><![CDATA[]]></description>
			<pubdate>3 Feb 2012, 09:30:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/DraftNICEGuidanceOnTestsToGuideBreastCancerTreatmentDecisions.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/ImprovingAccessToNICEApprovedDrugs.jsp]]></guid>
			<title>Improving access to NICE-approved drugs</title>
			<description><![CDATA[Improving access to NICE-approved drugs]]></description>
			<pubdate>2 Feb 2012, 11:15:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/ImprovingAccessToNICEApprovedDrugs.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/ImprovingAccessToNICEApprovedDrugs.jsp]]></guid>
			<title>Improving access to NICE-approved drugs</title>
			<description><![CDATA[Improving access to NICE-approved drugs]]></description>
			<pubdate>2 Feb 2012, 10:59:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/ImprovingAccessToNICEApprovedDrugs.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/AbirateroneProstateCancerACD.jsp]]></guid>
			<title>NICE consults on a new treatment for prostate cancer</title>
			<description><![CDATA[NICE, the healthcare guidance body, has issued new draft guidance not recommending the use of abiraterone (Zytiga, Janssen) in combination with prednisone or prednisolone for the treatment of castration-resistant metastatic prostate cancer that has progressed on or after docetaxel-containing therapy.]]></description>
			<pubdate>2 Feb 2012, 00:01:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/AbirateroneProstateCancerACD.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/PublicAskedForTheirViewsOnCommissioningOutcomesFramework.jsp]]></guid>
			<title>Public asked for their views on Commissioning Outcomes Framework (COF)</title>
			<description><![CDATA[Public asked for their views on Commissioning Outcomes Framework (COF)]]></description>
			<pubdate>1 Feb 2012, 10:27:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/PublicAskedForTheirViewsOnCommissioningOutcomesFramework.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/PublicAskedForTheirViewsOnCommissioningOutcomesFramework.jsp]]></guid>
			<title>Public asked for their views on Commissioning Outcomes Framework (COF)</title>
			<description><![CDATA[Public asked for their views on Commissioning Outcomes Framework (COF)]]></description>
			<pubdate>1 Feb 2012, 10:24:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/PublicAskedForTheirViewsOnCommissioningOutcomesFramework.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/BrainCoolingNewbornBabiesImprovedFollowingNICEGuidance.jsp]]></guid>
			<title>Brain cooling for newborn babies improved following NICE guidance</title>
			<description><![CDATA[Brain cooling for newborn babies improved following NICE guidance]]></description>
			<pubdate>31 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/BrainCoolingNewbornBabiesImprovedFollowingNICEGuidance.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/BrainCoolingNewbornBabiesImprovedFollowingNICEGuidance.jsp]]></guid>
			<title>Brain cooling for newborn babies improved following NICE guidance</title>
			<description><![CDATA[Brain cooling for newborn babies improved following NICE guidance]]></description>
			<pubdate>31 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/BrainCoolingNewbornBabiesImprovedFollowingNICEGuidance.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/2013-14COFConsultation.jsp]]></guid>
			<title>2013/14 COF consultation opens</title>
			<description><![CDATA[NICE has today launched its first consultation on potential indicators for the proposed 2013/14 Commissioning Outcomes Framework (COF). Anyone with an interest in health is invited to comment on the 120 indicators, which cover a broad range of topics, including mental health, cancer and asthma.]]></description>
			<pubdate>1 Feb 2012, 09:30:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/2013-14COFConsultation.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEKeyRoleAdoptionGeneticTestsNHS.jsp]]></guid>
			<title>NICE to have 'key role' in adoption of genetic tests by NHS</title>
			<description><![CDATA[NICE to have 'key role' in adoption of genetic tests by NHS]]></description>
			<pubdate>27 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEKeyRoleAdoptionGeneticTestsNHS.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEKeyRoleAdoptionGeneticTestsNHS.jsp]]></guid>
			<title>NICE to have 'key role' in adoption of genetic tests by NHS</title>
			<description><![CDATA[NICE to have 'key role' in adoption of genetic tests by NHS]]></description>
			<pubdate>27 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEKeyRoleAdoptionGeneticTestsNHS.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/about_nice.jsp]]></guid>
			<title>Planning service delivery</title>
			<description><![CDATA[NICE commissioning guides offer support on cost-effective commissioning and service configuration. Our costing tools and forward planner help estimate the local cost of implementing guidance.]]></description>
			<pubdate>26 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/about_nice.jsp]]></link>
			
			
			<category>Cost saving and support</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutpublichealthguidance/about_public_health_guidance.jsp]]></guid>
			<title>Spending to save - public health</title>
			<description><![CDATA[Promoting good health and preventing ill health saves money. All of NICE's public health guidance has proven to be cost-effective.]]></description>
			<pubdate>26 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutpublichealthguidance/about_public_health_guidance.jsp]]></link>
			
			
			<category>Cost saving and support</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/donotdorecommendations/index.jsp]]></guid>
			<title>Reducing inefficiency</title>
			<description><![CDATA[NICE 'do not do' recommendations can help reduce inefficiency. &lt;br/&gt;&lt;br/&gt;The NICE 'do not do' recommendations database contains all the 'do not do' recommendations that have been made since 2007.]]></description>
			<pubdate>26 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/donotdorecommendations/index.jsp]]></link>
			
			
			<category>Cost saving and support</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/implementationtools/howtoguide/SummaryOfGuidanceRelevantToGeneralPracticeInJanuary2012.jsp]]></guid>
			<title>Summary of guidance important for general practice</title>
			<description><![CDATA[Key points from NICE guidance published in January 2012]]></description>
			<pubdate>25 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/implementationtools/howtoguide/SummaryOfGuidanceRelevantToGeneralPracticeInJanuary2012.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/features/CommissioningServicesForCOPD.jsp]]></guid>
			<title>Commissioning services for COPD</title>
			<description><![CDATA[Advice for practices on improving services for patients with COPD.]]></description>
			<pubdate>25 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/features/CommissioningServicesForCOPD.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NewAdviceOnAntiEpilepticDrugs.jsp]]></guid>
			<title>New advice on anti-epileptic drugs</title>
			<description><![CDATA[Advice for GPs on when newer AEDs should be considered alongside older medicines.]]></description>
			<pubdate>25 Jan 2012, 10:10:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NewAdviceOnAntiEpilepticDrugs.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NewAdviceOnAntiEpilepticDrugs.jsp]]></guid>
			<title>New advice on anti-epileptic drugs</title>
			<description><![CDATA[New advice on anti-epileptic drugs]]></description>
			<pubdate>25 Jan 2012, 09:44:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NewAdviceOnAntiEpilepticDrugs.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NewAdviceOnAntiEpilepticDrugs.jsp]]></guid>
			<title>New advice on anti-epileptic drugs</title>
			<description><![CDATA[]]></description>
			<pubdate>25 Jan 2012, 09:41:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NewAdviceOnAntiEpilepticDrugs.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/BronchialThermoplastyGuidance.jsp]]></guid>
			<title>Increase monitoring for severe asthma treatment, says NICE</title>
			<description><![CDATA[Doctors who are considering offering a treatment for severe asthma, which involves heating the tissue of the lung airways, should take special care when deciding who to offer the procedure to and ensure that patients are fully informed about what is involved. This is because NICE has said that further research is still needed to show that the procedure is safe and clinically effective in the long term.]]></description>
			<pubdate>25 Jan 2012, 00:01:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/BronchialThermoplastyGuidance.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEApprovesNewGenerationCTScanners.jsp]]></guid>
			<title>NICE approves new generation CT scanners</title>
			<description><![CDATA[NICE approves new generation CT scanners]]></description>
			<pubdate>25 Jan 2012, 10:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEApprovesNewGenerationCTScanners.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEApprovesNewGenerationCTScanners.jsp]]></guid>
			<title>NICE approves new generation CT scanners</title>
			<description><![CDATA[NICE approves new generation CT scanners]]></description>
			<pubdate>25 Jan 2012, 10:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEApprovesNewGenerationCTScanners.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEGuidanceOnNewGenerationCardiacCTScanners.jsp]]></guid>
			<title>NICE guidance on new generation cardiac CT scanners set to improve diagnosis and management of coronary artery disease</title>
			<description><![CDATA[NICE has published guidance as part of its diagnostics assessment programme supporting the use of four new generation cardiac computed tomography (CT) scanners for people with suspected or known coronary artery disease (CAD) in whom imaging is difficult with earlier generation CT scanners.]]></description>
			<pubdate>25 Jan 2012, 00:05:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEGuidanceOnNewGenerationCardiacCTScanners.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/ApixabanForVTE.jsp]]></guid>
			<title>NICE approves new drug to prevent blood clots after hip and knee surgery</title>
			<description><![CDATA[NICE has published final guidance recommending the use of apixaban (Eliquis, Bristol-Myers Squibb and Pfizer) as an option for the prevention of venous thromboembolism (VTE) in adults who have undergone planned total hip replacement or total knee replacement surgery.]]></description>
			<pubdate>25 Jan 2012, 00:04:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/ApixabanForVTE.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NursesFollowNICEBloodClotGuidelines.jsp]]></guid>
			<title>Nurses follow NICE blood clot guidelines</title>
			<description><![CDATA[Nurses follow NICE blood clot guidelines]]></description>
			<pubdate>19 Jan 2012, 11:35:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NursesFollowNICEBloodClotGuidelines.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NursesFollowNICEBloodClotGuidelines.jsp]]></guid>
			<title>Nurses follow NICE blood clot guidelines</title>
			<description><![CDATA[]]></description>
			<pubdate>19 Jan 2012, 11:32:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NursesFollowNICEBloodClotGuidelines.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/ImproveHealthOfNHSWorkforceExpertsSay.jsp]]></guid>
			<title>Improve health of NHS workforce, experts say</title>
			<description><![CDATA[Improve health of NHS workforce, experts say]]></description>
			<pubdate>13 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/ImproveHealthOfNHSWorkforceExpertsSay.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/ImproveHealthOfNHSWorkforceExpertsSay.jsp]]></guid>
			<title>Improve health of NHS workforce, experts say</title>
			<description><![CDATA[]]></description>
			<pubdate>13 Jan 2012, 11:17:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/ImproveHealthOfNHSWorkforceExpertsSay.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICERecommendsNewTreatmentForCML.jsp]]></guid>
			<title>NICE recommends new treatment for CML</title>
			<description><![CDATA[NICE, the healthcare guidance body, has today published final guidance recommending a new treatment for chronic myeloid leukaemia (CML).]]></description>
			<pubdate>13 Jan 2012, 00:02:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICERecommendsNewTreatmentForCML.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/ExenatideForType2DiabetesFAD.jsp]]></guid>
			<title>NICE gives green light to prolonged-release exenatide for type 2 diabetes in final draft guidance</title>
			<description><![CDATA[In final draft guidance published today (Friday 13 January) NICE, the healthcare guidance body, has confirmed its initial draft recommendation of prolonged release exenatide (Bydureon, Eli Lilly) in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) as a treatment option for some people with type 2 diabetes.]]></description>
			<pubdate>13 Jan 2012, 00:01:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/ExenatideForType2DiabetesFAD.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/EndOfLifeCareCommissioning.jsp]]></guid>
			<title>Advice from NICE aims to improve commissioning for end of life care</title>
			<description><![CDATA[NICE has published its guide for commissioners of end-of-life care services, the latest in its series of good practice guides to support commissioners in designing high quality, evidence-based services to improve outcomes for patients and to help the NHS make better use of resources.]]></description>
			<pubdate>11 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/EndOfLifeCareCommissioning.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/CabazitaxelForProstateCancerFAD.jsp]]></guid>
			<title>NICE unable to endorse new treatment for prostate cancer</title>
			<description><![CDATA[NICE, the healthcare guidance body, has today published final draft guidance not recommending cabazitaxel (Jevtana, Sanofi) in combination with prednisone or prednisolone as a second line treatment for prostate cancer.]]></description>
			<pubdate>12 Jan 2012, 00:01:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/CabazitaxelForProstateCancerFAD.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEOpensUpAccessToTheLancet.jsp]]></guid>
			<title>NICE opens up access to The Lancet</title>
			<description><![CDATA[NICE opens up access to The Lancet]]></description>
			<pubdate>11 Jan 2012, 10:34:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEOpensUpAccessToTheLancet.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEOpensUpAccessToTheLancet.jsp]]></guid>
			<title>NICE opens up access to The Lancet</title>
			<description><![CDATA[]]></description>
			<pubdate>11 Jan 2012, 10:29:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEOpensUpAccessToTheLancet.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEFundsOpenOnlineAccessToTheLancet.jsp]]></guid>
			<title>NICE funds open online access to The Lancet for NHS and social care staff in England</title>
			<description><![CDATA[As part of its drive to provide open access to high quality evidence, the National Institute for Health and Clinical Excellence (NICE) has signed a three-year agreement with Elsevier to fund a national subscription to the online version of The Lancet.]]></description>
			<pubdate>11 Jan 2012, 10:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEFundsOpenOnlineAccessToTheLancet.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEUpdatesEpilepsyDrugAdvice.jsp]]></guid>
			<title>NICE updates epilepsy drug advice</title>
			<description><![CDATA[From today (Wednesday 11 January), doctors will have new advice on the drugs they should prescribe their patients who have epilepsy. This comes as the National Institute for Health and Clinical Excellence (NICE), the healthcare guidance body, updates the pharmacological recommendations from its clinical guideline on the diagnosis and management of the condition.]]></description>
			<pubdate>11 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/NICEUpdatesEpilepsyDrugAdvice.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/joinnwc/join_a_nice_committee_or_working_group.jsp]]></guid>
			<title>Join a NICE committee</title>
			<description><![CDATA[NICE committees and working groups are made up of health and other professionals, patients, carers and members of the public, and technical experts.]]></description>
			<pubdate>6 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/joinnwc/join_a_nice_committee_or_working_group.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/qof/qof.jsp]]></guid>
			<title>Qualtity and outcomes framework (QOF)</title>
			<description><![CDATA[&lt;p&gt;NHS oversees the development of indicators used to shwo that GPs should be rewarded for providing good quality clinical care and for helping to improve people's health. These indicators are part of the quality and outcomes framework (QOF), a voluntary incentive scheme for GP practices in the UK.&lt;/p&gt;]]></description>
			<pubdate>19 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/qof/qof.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/qualitystandards/qualitystandards.jsp]]></guid>
			<title>Quality standards</title>
			<description><![CDATA[&lt;p&gt;NHS is developing and defining the standards of healthcare that people can expect to receive. These standards will indicate when a clinical treatment (or set of clinical procedures) is considered highly effective, cost effective and safe as well as being viewed as a positive experience by patients.&lt;/p&gt;]]></description>
			<pubdate>19 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/qualitystandards/qualitystandards.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://guidance.nice.org.uk/CG/Wave21/1/Consultation/Latest]]></guid>
			<title>Acute upper GI bleeding:</title>
			<description><![CDATA[Guideline consultation]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://guidance.nice.org.uk/CG/Wave21/1/Consultation/Latest]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/examplesofimplementation/examples_of_implementation.jsp]]></guid>
			<title>Shared Learning Awards</title>
			<description><![CDATA[The Shared Learning Award winners include 18 projects in practice in the NHS, local authorities, voluntary and other organisations]]></description>
			<pubdate>18 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/examplesofimplementation/examples_of_implementation.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></guid>
			<title>Lay members' perspectives</title>
			<description><![CDATA[Our lay members share their thoughts on what it's like being part of a group that develops our guidance.]]></description>
			<pubdate>17 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/sharedlearningawards/about.jsp]]></guid>
			<title>Manchester Royal Infirmary</title>
			<description><![CDATA[Manchester Royal Infirmary has developed an innovative approach to dialysis delivery which empowers patients to perform haemodiaylsis at home]]></description>
			<pubdate>16 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/sharedlearningawards/about.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/qualitystandards/qualitystandards.jsp]]></guid>
			<title>Quality standards</title>
			<description><![CDATA[&lt;p&gt;NHS is developing and defining the standards of healthcare that people can expect to receive. These standards will indicate when a clinical treatment (or set of clinical procedures) is considered highly effective, cost effective and safe as well as being viewed as a positive experience by patients.&lt;/p&gt;]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/qualitystandards/qualitystandards.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.evidence.nhs.uk/]]></guid>
			<title>NHS Evidence</title>
			<description><![CDATA[&lt;p&gt;NHS Evidence is one of the most significant resources to be developed in recent years providing everyone working across health and social care with easy access to a wealth of quality informationand best practice so that every care decision made can be based on the best possible evidence.&lt;/p&gt;]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.evidence.nhs.uk/]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/DasatinibImatinibAndNilotinibForIRIICMLFAD.jsp]]></guid>
			<title>Price discount means NICE can recommend a new drug for chronic myeloid leukaemia</title>
			<description><![CDATA[In new draft guidance NICE has recommended nilotnib also know as Tasigna and made by Novartis, for the treatment of chronic and accelerated phases of CML (chronic myeloid leukaemia) that is resistant or intoloerant to standard-dose imatinib, Dasatinib (Spycel), made by Bristol-Myers Squibb is not recommended for CML that is resistant or intoleratnt to standard-dose imatinib, and hight-dose imatinib (Gilvec) made by Novartis, is not recommended by CML is resistant to standards dose....]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/DasatinibImatinibAndNilotinibForIRIICMLFAD.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/GreaterSupportForLocalGovernment.jsp]]></guid>
			<title>Greater support for local government in new public health role</title>
			<description><![CDATA[Greater support for local government in new public health role]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/GreaterSupportForLocalGovernment.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/features/HowShouldNICEAssessFutureCostsAndHealthBenefits.jsp]]></guid>
			<title>Feature: Assessing future costs</title>
			<description><![CDATA[Should immediate costs and health benefits be treated differently from those that occur in the future? This was the latest topic for NICE's Citizens Council.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/features/HowShouldNICEAssessFutureCostsAndHealthBenefits.jsp]]></link>
			
			
			<category>Behind the Headlines</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/benefitsofimplementation/costsavingguidance.jsp]]></guid>
			<title>Using resources efficiently</title>
			<description><![CDATA[Following NICE guidance helps organisations deliver quality care for patients and service users and shows service providers how to best spend limited resources. We have produced a list of guidance which we consider deliver savings.]]></description>
			<pubdate>14 Jan 2012, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/benefitsofimplementation/costsavingguidance.jsp]]></link>
			
			
			<category>Cost saving and support</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/publicmeetings/publicmeetings.jsp]]></guid>
			<title>Public meetings</title>
			<description><![CDATA[NICE's advisory committee meetings, technology appraisal appeal hearings and board meetings are open to the public and press to observe. Holding these meetings in public supports NICE's commitment to having processes in place that are rigorous, open and transparent.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/publicmeetings/publicmeetings.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/factsheets/factsheets.jsp]]></guid>
			<title>NICE fact sheets</title>
			<description><![CDATA[Our fact sheets provide background information on some aspects of NICE's work.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/factsheets/factsheets.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/features/Features.jsp]]></guid>
			<title>Features</title>
			<description><![CDATA[Our features take an in-depth look at the work that NICE does and how our guidance can improve care for patients and empower health professionals to deliver the most clinically- and cost-effective care.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/features/Features.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/events/events.jsp]]></guid>
			<title>NICE events</title>
			<description><![CDATA[NICE exhibits at a number of events organised by other organisations, to ensure that those with an interest in the work of NICE have an understanding of our purpose, processes, products and contribution to healthcare.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/events/events.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/press_releases.jsp]]></guid>
			<title>Media centre</title>
			<description><![CDATA[The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/press_releases.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></guid>
			<title>NICE for commissioners</title>
			<description><![CDATA[NICE's role in the new commissioning system, and the practical support we can provide.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></guid>
			<title>My NICE resources</title>
			<description><![CDATA[Using NICE guidance in your professional education, and how this can help with appraisal and revalidation.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAnnualConference2012ProgrammeUnveiled.jsp]]></guid>
			<title>NICE Annual Conference 2012</title>
			<description><![CDATA[The NICE annual conference will take place on 15 - 16 May 2012, at the ICC in Birmingham. Book your place now, and you will benefit from 2011's early booking rate, for a limited time only.]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAnnualConference2012ProgrammeUnveiled.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></guid>
			<title>Using NICE guidance in practice</title>
			<description><![CDATA[What should happen in a well run practice when NICE published new guidance? How to test whether your practice is up to date, and ways to provide and use feedback]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/about_nice.jsp]]></guid>
			<title>Your stories wanted</title>
			<description><![CDATA[If you already have a good system for using NICE guidance, or have used a guideline to improve patient care, please tell us so we can share your story.&lt;br/&gt;&lt;br/&gt;Emails us at&lt;br/&gt;&lt;a href=&quot;mailto:general.practice@nice.org.uk&quot;&gt;general.practice@nice.org.uk&lt;/a&gt;]]></description>
			<pubdate>14 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/about_nice.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/about_nice_guidance_what_does_it_mean_for_me.jsp]]></guid>
			<title>coming soon......</title>
			<description><![CDATA[NICE expects to issue guidance in February on type 2 diabetes- exenatide]]></description>
			<pubdate>14 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/about_nice_guidance_what_does_it_mean_for_me.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></guid>
			<title>NICE for my patients</title>
			<description><![CDATA[Resources to help you to find timely and up to date advice for your patients, and links to services to support decision making at the point of care.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/nhsevidence/nhseac.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/patientsandpublic/index.jsp]]></guid>
			<title>Search for guidance written for patients and the public</title>
			<description><![CDATA[We produce versions of all our guidance for patients, carers and members of the public.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/patientsandpublic/index.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/news.jsp]]></guid>
			<title>Latest guidance news</title>
			<description><![CDATA[Take a look at the very latest news below and find out what is making the headlines.]]></description>
			<pubdate>25 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/news.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/joinnwc/join_a_nice_committee_or_working_group.jsp]]></guid>
			<title>Join a NICE committee or working group</title>
			<description><![CDATA[NICE committees and working groups are made up of health and other professionals, patients, carers and members of the public, and technical experts.]]></description>
			<pubdate>25 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/joinnwc/join_a_nice_committee_or_working_group.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/currentniceconsultations/current_nice_consultations.jsp]]></guid>
			<title>Comment on draft guidance</title>
			<description><![CDATA[Take a look at the very latest NICE consultations in date order for ease of use.]]></description>
			<pubdate>25 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/currentniceconsultations/current_nice_consultations.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/puttingguidanceintopractice.jsp]]></guid>
			<title>Putting our guidance into practice</title>
			<description><![CDATA[Find out how to put NICE guidance into practice, and how you can help.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/puttingguidanceintopractice.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientcoeliacgd.jsp]]></guid>
			<title>Lay members' perspectives</title>
			<description><![CDATA[Our lay members share their thoughts on what it's like being part of a group that develops our guidance.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientcoeliacgd.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/NICEPatientsAndPublic.jsp]]></guid>
			<title>How we involve patients and the public</title>
			<description><![CDATA[Our Patient and Public Involvement Programme welcomes your contribution.]]></description>
			<pubdate>25 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/NICEPatientsAndPublic.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientsandpublic/patientandpublichome.jsp]]></guid>
			<title>Developing our guidance with you</title>
			<description><![CDATA[Find out how you can suggest a topic and how you can help us develop guidance.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientsandpublic/patientandpublichome.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/guidetonice/a_guide_to_nice.jsp]]></guid>
			<title>About NICE 1</title>
			<description><![CDATA[NICE guidance helps health and social care professionals deliver the best possible care based on the best available evidence.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/guidetonice/a_guide_to_nice.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/what_we_do.jsp]]></guid>
			<title>We provide independent, authoritative and evidence-based guidance on the most effective ways to prevent, diagnose and treat disease and ill health, reducing inequalities and variation</title>
			<description><![CDATA[Our guidance is for the NHS, local authorities, charities, and anyone with a responsibility for commissioning or providing healthcare, public health or social care services. We also support these groups in putting our guidance into practice.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/what_we_do.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/what_we_do.jsp]]></guid>
			<title>Providing guidance to ensure quality and value for money</title>
			<description><![CDATA[NICE guidance supports healthcare professionals and others to make sure that the care they provide is of the best possible quality and offers the best value for money.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/what_we_do.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/howwework/how_we_work.jsp]]></guid>
			<title>How we work</title>
			<description><![CDATA[We develop our guidance and other products by working with experts from the NHS, local authorities, and others in the public, private and voluntary sectors - including patients and the public. &lt;br/&gt;&lt;br/&gt;Our recommendations are based on the best available evidence of the most effective care. Our guidance is produced openly and transparently, and we make sure that those that use our guidance, as well as those it affects, are involved every step of the way.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/howwework/how_we_work.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutdiagnosticsassessment/diagnosticsassessmentprogramme.jsp]]></guid>
			<title>Diagnostics Assessment Programme</title>
			<description><![CDATA[&lt;p&gt;Diagnostics Assessment Programme (DAP) focuses on the evaluation of innovative medical diagnostic technologies in order to ensure that the NHS is able to adopt clinically and cost effective technologies rapidly and consistently.&lt;/p&gt;]]></description>
			<pubdate>17 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutdiagnosticsassessment/diagnosticsassessmentprogramme.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutmedicaltechnologies/MTEPProcessGuideAndMethodsGuide.jsp]]></guid>
			<title>Medical technologies</title>
			<description><![CDATA[&lt;p&gt;The Medical Technologies Evaluation Programme (MTEP) focuses specifically on the selection and evaluation of new or innovative medical technologies (including devices and diagnostics).&lt;/p&gt;]]></description>
			<pubdate>15 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutmedicaltechnologies/MTEPProcessGuideAndMethodsGuide.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutinterventionalprocedures/about_interventional_procedures.jsp]]></guid>
			<title>Interventional procedures</title>
			<description><![CDATA[&lt;p&gt;An interventional procedure is a procedure used for diagnosis or for treatment that involves making a cut or hole to gain access to the inside of a patient's body, gaining access to a body cavity or using electromagnetic radiation.&lt;/p&gt;]]></description>
			<pubdate>15 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutinterventionalprocedures/about_interventional_procedures.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/sharedlearningawards/about.jsp]]></guid>
			<title>Manchester Royal Infirmary</title>
			<description><![CDATA[Manchester Royal Infirmary has developed an innovative approach to dialysis delivery which empowers patients to perform haemodiaylsis at home]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/sharedlearningimplementingniceguidance/sharedlearningawards/about.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutpublichealthguidance/about_public_health_guidance.jsp]]></guid>
			<title>Public health guidance</title>
			<description><![CDATA[&lt;p&gt;Public health guidance makes recommendations for populations and individuals on the activities, policies and strategies that can help prevent disease or improve health.&lt;/p&gt;]]></description>
			<pubdate>16 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutpublichealthguidance/about_public_health_guidance.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/abouttechnologyappraisals/about_technology_appraisals.jsp]]></guid>
			<title>Technology appraisals</title>
			<description><![CDATA[&lt;p&gt;Technology appraisals are recommendations on the use of new and existing medicines and treatments within the NHS.&lt;/p&gt;]]></description>
			<pubdate>15 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/abouttechnologyappraisals/about_technology_appraisals.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutclinicalguidelines/about_clinical_guidelines.jsp]]></guid>
			<title>Clinical guidelines</title>
			<description><![CDATA[&lt;p&gt;Clinical guidelines are recommendations by NICE no the appropriate treatment and care of people with specific diseases and conditions within the NHS. They are based on the best available evidence.&lt;/p&gt;]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutclinicalguidelines/about_clinical_guidelines.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></guid>
			<title>Putting our guidance into practice</title>
			<description><![CDATA[Find out how to put NICE guidance into practice, and how you can help.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></guid>
			<title>How we involve patients and the public</title>
			<description><![CDATA[Our Patient and Public involvement Programme welcomes your contribution.]]></description>
			<pubdate>8 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></guid>
			<title>Developing our guidance with you:</title>
			<description><![CDATA[Find out how you can suggest a topic and how you can help us develop guidance.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientandpublicinvolvement/patientandpublicinvolvement.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/joinnwc/join_a_nice_committee_or_working_group.jsp]]></guid>
			<title>We are committed to involving professionals, patients, carers and the public in the development of our guidance.</title>
			<description><![CDATA[You can help shape the recommendations we make by joining one of our committees.]]></description>
			<pubdate>8 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/joinnwc/join_a_nice_committee_or_working_group.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.evidence.nhs.uk/]]></guid>
			<title>NHS Evidence</title>
			<description><![CDATA[NHS Evidence is a service that provides fast access to authoritative health and social care evidence and best practice through a web-based portal. In one place, you can simultaneously search over 250,000 resources from hundreds of trustworthy and accredited sources including The Cochrane Library, NICE and Royal Colleges.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.evidence.nhs.uk/]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/currentniceconsultations/current_nice_consultations.jsp]]></guid>
			<title>Tell us what you think</title>
			<description><![CDATA[We run consultations that allow interested organisations and members of the public to comment on all of our guidance in draft format, before it is finalised. Have your say today.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/currentniceconsultations/current_nice_consultations.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientsandpublic/patientandpublichome.jsp]]></guid>
			<title>Patients and the public</title>
			<description><![CDATA[We know our guidance has a big impact on patients, carers and the public - so we involve you in every stage of our guidance development.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientsandpublic/patientandpublichome.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.npc.nhs.uk/]]></guid>
			<title>National Prescribing Centre</title>
			<description><![CDATA[The National Prescribing Centre, which became part of NICE on 1 April 2011, provides support and e-learning materials to help health and medical professionals implement guidance on medicines and technologies. The NPC works to improve quality, safety, and value for money in the use of medicines.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.npc.nhs.uk/]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nelm.nhs.uk/en/]]></guid>
			<title>National Electronic Library of Medicines</title>
			<description><![CDATA[NeLM is the largest medicines information portal for healthcare professionals in the UK National Health Service (NHS). It aims to promote the safe, effective and efficient use of medicines.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nelm.nhs.uk/en/]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://bnf.org/bnf/index.htm]]></guid>
			<title>British National Formulary</title>
			<description><![CDATA[The BNF provides UK healthcare professionals with authoritative and practical information on the selection and clinical use of medicines in a clear, concise and accessible manner.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://bnf.org/bnf/index.htm]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/currentniceconsultations/current_nice_consultations.jsp]]></guid>
			<title>Guidance in development</title>
			<description><![CDATA[There are consultation stages during the guidance development process when stakeholders and interested members of the public can comment on draft guidance.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/currentniceconsultations/current_nice_consultations.jsp]]></link>
			
			
			<category>Consultations</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/niceandthenhs/CostSaving.jsp]]></guid>
			<title>Using resources efficiently</title>
			<description><![CDATA[NICE has identified recommendations that could help the NHS save millions of pounds, whilst maintaining or improving the quality of care.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/niceandthenhs/CostSaving.jsp]]></link>
			
			
			<category>Cost saving and support</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/patientsandpublic/patientandpublichome.jsp]]></guid>
			<title>Putting patients at the centre of NICE's work</title>
			<description><![CDATA[Patients, carers and members of the public are crucial to NICE, playing a key role in shaping our recommendations.]]></description>
			<pubdate>13 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/patientsandpublic/patientandpublichome.jsp]]></link>
			
			
			<category>Patients and the public</category>
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/benefitsofimplementation/benefits_of_implementation.jsp]]></guid>
			<title>We produce a range of free support tools</title>
			<description><![CDATA[We produce a range of free support tools to help you put our guidance into practice - from costing templates and clinical audit to commissioning guides and slide sets.]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/benefitsofimplementation/benefits_of_implementation.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/benefitsofimplementation/benefits_of_implementation.jsp]]></guid>
			<title>Putting NICE guidance into practice benefits everyone</title>
			<description><![CDATA[Putting NICE guidance into practice benefits everyone - the public, patients, carers, the NHS and Local Authorities.]]></description>
			<pubdate>20 Oct 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/benefitsofimplementation/benefits_of_implementation.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/helpimplementniceguidance/help_implement_nice_guidance.jsp]]></guid>
			<title>Help implement NICE guidance</title>
			<description><![CDATA[&lt;p&gt;NICE actively seeks feedback from those involved in implementing our guidance, by contributing to and joining our panels and working group and by sending us your feedback on our processes and support materials.&lt;/p&gt;]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/helpimplementniceguidance/help_implement_nice_guidance.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/OrganDonationGuideline.jsp]]></guid>
			<title>NICE publishes new guideline on organ donation</title>
			<description><![CDATA[]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/pressreleases/OrganDonationGuideline.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/niceimplementationprogramme/nice_implementation_programme.jsp]]></guid>
			<title>NICE implementation programme</title>
			<description><![CDATA[&lt;p&gt;Putting NICE guidance into practice can be challenging. NICE has set up a programme to help support implementation. We believe that by working with the NHS local authorities private and voluntary sectors, and the wider public NICE can help ensure its gudance is implemented.&lt;/p&gt;]]></description>
			<pubdate>7 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/niceimplementationprogramme/nice_implementation_programme.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/usingguidance/commissioningguides/bytopic.jsp]]></guid>
			<title>Commissioning guides</title>
			<description><![CDATA[&lt;p&gt;NICE commissioning guides are topic-specific, web-based resources supporting clinical service redesign, Each commissioning guide signposts and provides topic-specific information on key clinical and service-related issues to consider during the commissioning process.&lt;/p&gt;]]></description>
			<pubdate>7 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/usingguidance/commissioningguides/bytopic.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAtHeartOfNewNHSCommissioningOutcomesFramework.jsp]]></guid>
			<title>NICE at heart of new NHS Commissioning Outcomes Framework</title>
			<description><![CDATA[]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/news/NICEAtHeartOfNewNHSCommissioningOutcomesFramework.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/getinvolved/nice_fellows_and_scholars/nicefellowsandscholars.jsp]]></guid>
			<title>NICE Fellows and Scholars</title>
			<description><![CDATA[NICE Fellows and Scholars programme fosters a growing network of health professionals linked to NICE who help to improve the quality of care.]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/getinvolved/nice_fellows_and_scholars/nicefellowsandscholars.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutmedicaltechnologies/medicaltechnologiesprogramme.jsp]]></guid>
			<title>Medical Technologies</title>
			<description><![CDATA[The Medical Technologies Evaluation Programme (MTEP) and Diagnostics Assessment Programme (DAP) are the newest additions to our work at NICE.]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/aboutmedicaltechnologies/medicaltechnologiesprogramme.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/qof/qof.jsp]]></guid>
			<title>Quality and Outcomes Framework (QOF)</title>
			<description><![CDATA[NICE has played a major role in shaping the Quality and Outcomes Framework (QOF) in 2010/11, by recommending new indicators to help improve the care of patients with conditions such as diabetes, dementia and mental health problems.]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/qof/qof.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/niceinternational/niceinternational.jsp]]></guid>
			<title>NICE International</title>
			<description><![CDATA[The NICE International team works on a fee-for-service basis with policy makers and clinicians around the world to promote evidence-based decision making in healthcare.]]></description>
			<pubdate>12 Dec 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/niceinternational/niceinternational.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/niceandthenhs/CostSaving.jsp]]></guid>
			<title>Find out more about NICE and cost saving</title>
			<description><![CDATA[NICE has identified 30 sets of recommendations that, if fully implemented, could help the NHS to save millions of pounds, whilst maintaining or improving the quality of care.]]></description>
			<pubdate>17 Nov 2011, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/aboutnice/whatwedo/niceandthenhs/CostSaving.jsp]]></link>
			
			
			
		</item>
		<item>
			<guid><![CDATA[http://www.nice.org.uk/newsroom/nicepressoffice/nice_press_office.jsp]]></guid>
			<title>There are no upcoming press events</title>
			<description><![CDATA[The next NICE press event will be publicised on this page. Please contact the NICE press team on 0845 003 7782 if you have any enquiries about future press events.]]></description>
			<pubdate>15 Jul 2010, 00:00:00</pubdate>
			<link><![CDATA[http://www.nice.org.uk/newsroom/nicepressoffice/nice_press_office.jsp]]></link>
			
			
			
		</item>
		
	</channel>
</rss>
